They could do a favor to themselves and to patients and skip avastin. Avastin is not for rgbm - the European are right. I would never test vb111 with avastin.
Too bad they didn't work with the European authorities to design a trial that would be independent of avastin. Would've been nice to see supporting data from Europe.